Amicus Therapeutics Inc is a biotechnology firm dedicated to tackling rare diseases. It's known for Galafold, an innovative oral treatment for adults with Fabry disease, a genetic disorder. The company also works on developing therapies for other conditions, including through partnerships like those with the University of Pennsylvania and GlaxoSmithKline. Founded in 2002 and based in Princeton, New Jersey, Amicus Therapeutics strives to bring precision medicine to those facing life-altering diagnoses.
Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back rally across the major indices on Wednesday, after the worst day for stocks since October. Stocks were headed…
Corcept Therapeutics (NASDAQ: CORT) and Amicus Therapeutics (NASDAQ: FOLD | FOLD Price Prediction) delivered Q3 2025 results highlighting two rare disease biotechs at opposite ends of the profitability spectrum. Corcept posted revenue…
Pre-Market Stock Futures: The futures are trading lower as we begin the final trading week of 2025, albeit a holiday-shortened one once again. The major indices all finished the session modestly lower…
Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week after an outstanding triple-witching Friday rally that may have kicked the “Santa Claus” rally into…
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Viking Therapeutics.
Are you looking for low-cost stocks to add to your portfolio? Doing so can be a challenge. After all, stocks that trade with low share prices are often risky investment opportunities. That’s…
Monday's top analyst upgrades and downgrades included Akamai Technologies, ChargePoint, Chevron, Costco Wholesale, Dollar Tree, Kimberly-Clark, Plains All American Pipeline and Shopify.
Thursday's top analyst upgrades and downgrades included Anheuser-Busch, Fiserv, Foot Locker, Fox, Kohl's, Snowflake, Starbucks, Williams-Sonoma and Zscaler.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Amicus Therapeutics, Bloomin' Brands, Children’s Place and Seagate Technology.
Wednesday's top analyst upgrades and downgrades included Alphabet, Facebook, Harley-Davidson, JetBlue Airways, Lowe's Companies, Occidental Petroleum, Overstock.com, Snap and Southwest Airlines.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Carnival, Norwegian Cruise Lines, Royal Caribbean and Switch.
Tuesday's top analyst upgrades and downgrades included Akamai Technologies, Beyond Meat, Broadcom, Dow, Morgan Stanley, Plug Power, TripAdvisor and Zoom Video Communications.
Friday's top analyst upgrades and downgrades included AngloGold Ashanti, Fisker, News Corp, QuantumScape, Williams-Sonoma, YETI and Zillow.
Monday's top analyst upgrades and downgrades included Activision Blizzard, Altice USA, Boeing, Booking, Rocket Companies, Truist Financial and Walgreens Boots Alliance.
Tuesday's top analyst upgrades and downgrades included Bed Bath & Beyond, Booking, Carvana, Electronic Arts, EOG Resources, Honeywell, Intercontinental Exchange, Livongo Health, Nucor, Seres Therapeutics and Sunrun.
